NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
77 hedge funds and large institutions have $60.5M invested in Niagen Bioscience, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+11
Holders Change %
+16.67%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
24
Reduced
20
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SA
Sycale Advisors
New York
|
+$850K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$817K |
| 3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$694K |
| 4 |
Morgan Stanley
New York
|
+$689K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$566K |
Top Sellers
| 1 |
Bessemer Group
Woodbridge,
New Jersey
|
-$532K |
| 2 |
Renaissance Technologies
New York
|
-$516K |
| 3 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$323K |
| 4 |
Two Sigma Investments
New York
|
-$269K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$206K |
